Apretude
Payments companies reported to CMS as associated with Apretude. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Apretude, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Apretude
These are the largest totals companies reported as associated with Apretude. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kevin Hatfield | Seattle, WA | Family Medicine | $296,492.84 |
| Nasser Mohamed | San Francisco, CA | Family Medicine | $172,484.22 |
| Douglas Cunningham | Phoenix, AZ | Family Medicine | $171,112.50 |
| David Bekhor | New York, NY | Infectious Disease | $167,344.05 |
| Zandraetta Tims-Cook | Atlanta, GA | Infectious Disease | $155,476.63 |
| Theo Hodge | Washington, DC | Infectious Disease | $148,922.24 |
| Noah Lee | Oakland Park, FL | Family Medicine | $135,677.54 |
| Koppany Visnyei | Los Angeles, CA | Internal Medicine | $135,080.01 |
| Ronald Collazo Pagan | Manati, PR | Internal Medicine | $127,663.24 |
| Alexea Gaffney-Adams | E. Setauket, NY | Internal Medicine | $125,239.03 |
Prescribed Apretude?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.